Steadybase.

Amarin Corp Plc\uk.

Website LinkedIn Latest 10-K
  • AMRN · Nasdaq
  • Pharmaceutical Preparations
  • Dublin 2, Ireland
  • CIK 0000897448

Updated from SEC filings through

Top things to know

Executives

What leadership is saying

“Our results in the third quarter demonstrate the continued positive trajectory in our operational, financial and strategic transformation, underscoring the progress we are making to strengthen our business, expand the value of our VASCEPA®/VAZKEPA® (icosapent ethyl, or IPE) franchise and deliver long-term shareholder value”

Aaron Berg, President & Chief Executive Officer
Earnings press release (8-K Ex. 99.1), filed October 28, 2026

Amarin Corp Plc\uk is a U.S. public company in pharmaceutical preparations (SIC 2834), headquartered in Dublin 2, Ireland. It trades as AMRN on Nasdaq. Revenue was $214M in the fiscal year ending December 31, 2025, -6.5% from the year before.

Five-year financials

MetricFY2025FY2024FY2023FY2022FY2021
Revenue $214M
10-K, 2026-03-02
$229M
10-K, 2026-03-02
$307M
10-K, 2026-03-02
$369M
10-K, 2025-03-12
$583M
10-K, 2024-02-29
Operating income -$50.2M
10-K, 2026-03-02
-$91.8M
10-K, 2026-03-02
-$67.6M
10-K, 2026-03-02
-$106M
10-K, 2025-03-12
$10.5M
10-K, 2024-02-29
SG&A $115M
10-K, 2026-03-02
$152M
10-K, 2026-03-02
$200M
10-K, 2026-03-02
$304M
10-K, 2025-03-12
$408M
10-K, 2024-02-29
Net income -$38.8M
10-K, 2026-03-02
-$82.2M
10-K, 2026-03-02
-$59.1M
10-K, 2026-03-02
-$106M
10-K, 2025-03-12
$7.7M
10-K, 2024-02-29

Annual figures from XBRL in each company's own filings. Click a figure to open the filing. SG&A marked derived is general and administrative plus selling and marketing.

Leadership and board

NameTitleSource
Aaron Berg Aaron Berg President & Chief Executive Officer 8-K, October 28, 2026
Peter Fishman Peter Fishman Amarin’s Chief Financial Officer 8-K, October 28, 2026
Jonathan Provoost Jonathan Provoost
Executive Vice President, Chief Legal & Compliance Officer, Corporate Secretary at Amarin Corp.
EVP, Chief Legal Officer Form 4, July 15, 2026
David Paul Keenan EVP, Chief Operating Officer Form 4, July 15, 2026
Steven B. Ketchum EVP, Chief Scientific Officer Form 4, July 15, 2026
Diane E. Sullivan Director 10-K, March 2, 2026
Keith L. Horn Director 10-K, March 2, 2026
Louis Sterling III. Director 10-K, March 2, 2026
Michael Torok Director 10-K, March 2, 2026
Odysseas Kostas, M.D. Director 10-K, March 2, 2026
Oliver O'Connor Director 10-K, March 2, 2026
Patrice Bonfiglio Director 10-K, March 2, 2026
Paul Cohen, M.D. Director 10-K, March 2, 2026

Shares and governance

Shares outstanding 380,694 (as of February 20, 2013) 10-K, February 28, 2013
Public float $335M (as of June 30, 2025) 10-K, March 2, 2026
Reportable segments 1 (period ending September 30, 2026) 10-Q, October 28, 2026
Latest proxy statement Meeting April 10, 2026 (filed April 10, 2026) DEF 14A, April 10, 2026
Auditor Ernst & Young LLP (Iselin, New Jersey) Latest 10-K

Recent 8-K events

Frequently asked questions about Amarin Corp Plc\uk

What does Amarin Corp Plc\uk do?
Amarin Corp Plc\uk is classified by the SEC as Pharmaceutical Preparations (SIC 2834). It is based in Dublin 2, Ireland.
What is Amarin Corp Plc\uk's revenue?
$214M for the fiscal year ending December 31, 2025, from its 10-K filed March 2, 2026.
Is Amarin Corp Plc\uk profitable?
Amarin Corp Plc\uk reported net income of -$38.8M for the fiscal year ending December 31, 2025.
Who is the CFO of Amarin Corp Plc\uk?
Peter Fishman, Amarin’s Chief Financial Officer, as named in a 8-K filed October 28, 2026.
Where is Amarin Corp Plc\uk headquartered?
Dublin 2, Ireland.
What is Amarin Corp Plc\uk's stock ticker?
AMRN on Nasdaq.
What industry is Amarin Corp Plc\uk in?
Pharmaceutical Preparations, SIC code 2834.
What is Amarin Corp Plc\uk's website?
amarincorp.com.
When does Amarin Corp Plc\uk report earnings next?
January 20, 2027. This is an estimate from past filing dates, not a confirmed date.
Is Amarin Corp Plc\uk a public company?
Yes. Amarin Corp Plc\uk files with the SEC under CIK 0000897448 and trades as AMRN.
Who audits Amarin Corp Plc\uk?
Ernst & Young LLP, Iselin, New Jersey, as named in its latest annual report (10-K).
How many shares of Amarin Corp Plc\uk are outstanding?
380,694 shares as of February 20, 2013, from its 10-K filed February 28, 2013.
What is Amarin Corp Plc\uk's public float?
$335M as of June 30, 2025, as reported on the cover of its 10-K filed March 2, 2026.
How many business segments does Amarin Corp Plc\uk report?
1 reportable segment for the period ending September 30, 2026, from its 10-Q filed October 28, 2026.
When is Amarin Corp Plc\uk's annual shareholder meeting?
April 10, 2026, per its proxy statement (DEF 14A) filed April 10, 2026.